A modified TOM2A gene mediates resistance to tobamoviruses.

Abstract

The present invention relates to a plant comprising a modified Tom2a gene, the wild type of which comprises SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, or SEQ ID NO:6, or another homologous sequence having at least 70% sequence identity to SEQ ID NO:1, which modified gene results in increased resistance to tobamovirus. The modification in the Tom2a gene results in a modified Tom2a protein having at least one amino acid deletion, substitution, or insertion compared to SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, or SEQ ID NO:12, or another homologous sequence having at least 70% sequence similarity to SEQ ID NO:7. The plant is preferably a plant of the Cucurbitaceae or Solanaceae family. The present invention further relates to a modified Tom2a gene encoding a Tom2a protein comprising at least one amino acid deletion, substitution, or insertion when compared to SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, or SEQ ID NO:12, or another homologous sequence having at least 70% sequence similarity to SEQ ID NO:7.

Description

[Technical field]

[0001] The present invention relates to plants comprising modified genes that provide resistance to tobamoviruses. The present invention further relates to methods for producing such plants, for identifying the modified genes, and for selecting such plants. The present invention also relates to modified genes and the use of said genes to confer or increase tobamovirus resistance in plants. The present invention also relates to markers for the identification of modified genes in plants, and the use of said markers. [Background technology]

[0002] Wherever agriculture is practiced, both in protected and open cultivation, viral diseases pose one of the major threats facing vegetable growers. Initial infection can occur through the use of infected seed, or through physical or insect transmission. Once a crop is infected, spread of the virus can occur rapidly, through physical sap transfer through the use of tools and cultivation methods, or through vectors such as insects that are difficult to control.

[0003] Tobamoviruses are often seed-borne and then mostly spread by physical transmission. Insects are not specifically involved in the transmission of tobamoviruses. Common symptoms of tobamovirus infection include yellowing to leaf chlorosis, severe or mild mosaic disease, leaf distortion, and fruit symptoms. Tobamoviruses are positive-stranded RNA viruses that replicate in highly specialized replication compartments that form globular or vesicular structures in certain membranes. The viral positive-stranded RNA synthesized in these compartments is released into the cytoplasm, using the negative-stranded RNA as a template, through narrow channels that connect the inner space of the compartment to the cytoplasm. Under standard circumstances, the presence of this very narrow channel appears to prevent contact between the components involved in virus synthesis and the antiviral defense mechanisms available to the host plant.

[0004] Many genes are recognized as genes involved in virus resistance, for example because they are known to be part of the virus replication process necessary for the virus to infect the host. Virus resistance can be based on different mechanisms and can involve different stages of plant development and different plant defense pathways. However, even when a gene is known to be part of the virus replication mechanism, it is not always clear how the gene should or can be modified to prevent the virus from usurping the original role of the gene. Summary of the Invention

[0005] An object of the present invention is to provide a plant which exhibits resistance to viruses belonging to the genus Tobamovirus, in particular to Cucumber green mottle mosaic virus (CGMMV) or Tomato brown rugose fruit virus (ToBRFV).

[0006] In plant breeding research, the search for new genetic resources for virus resistance is constantly ongoing. Constant adaptation to new or more potent virus variants is necessary to develop new varieties that can help growers deal with ever-present disease challenges. The research leading to the present invention focused on identifying and developing new genes of resistance to tobamoviruses that infect various crops, particularly Cucurbitaceae and Solanaceae. In cucumber (Cucumis sativus), the tobamovirus species CGMMV is an important disease, and resistance, even if present, is not absolute, and stacking of different resistance backgrounds is common. To search for new resistances, a large EMS population was developed and various variants in many genes were identified by applying the TILLING approach. Among the variants resulting in stop variants, splice sites, and amino acid changes, those predicted to be dramatically altered when applying SIFT prediction were selected.

[0007] Tom2a is one of the genes from which a large number of potentially interesting EMS TILLING mutants were obtained (Example 1). Two mutants resulted in premature stop codons, resulting in truncated Tom2a proteins lacking many domains thought to be essential for the proper function of the Tom2a protein. In addition, four mutants were identified that resulted in amino acid changes predicted to be dramatic, i.e., to affect the function of the protein. The stop mutant was expected to be particularly interesting because it lacks at least part of the critical C-terminal tail of the protein. One of these mutants, a mutant with a Q268 stop mutation in the encoded cucumber Tom2a protein, was first phenotyped (Example 2) to understand the potential of Tom2a mutants for general virus resistance.

[0008] In co-pending PCT / EP2021 / 070104, the identification of several modifications in the Tom2a gene of Solanum pimpinellifolium is described. PCT / EP2021 / 070104 discloses the GGC312-314del modification, the A559G substitution, the G673A substitution, and the A844G substitution in the Tom2a gene of Solanum lycopersicum (tomato). The introduction of these modifications into Solanum lycopersicum is described and the presence of one or more of these modifications in the Tom2a gene of S. lycopersicum is shown to increase ToBRFV resistance. The combined findings of CGMMV resistance in cucumber and ToBRFV resistance in tomato through Tom2a modifications may form a good basis for extrapolating the presence of these or similar modifications in homologous Tom2a genes in other crops, particularly in cucurbit-related crops and solanaceae-related crops, which could improve tobamovirus resistance, particularly CGMMV resistance in cucurbits or ToBRFV resistance in solanaceae.

[0009] The present invention provides a plant comprising a modified Tom2a gene, which provides increased resistance to tobamoviruses. In particular, the presence of a modified Tom2a gene provides increased resistance to tobamoviruses in plants belonging to the Solanaceae family or plants belonging to the Cucurbitaceae family. The plant comprising a modified Tom2a gene is preferably a plant of the Cucurbitaceae family or Solanaceae family, in particular a plant of the species Cucumis sativus, Cucumis melo, Citrullus lanatus, Cucurbita pepo, Solanum lycopersicum or Capsicum annuum. The plant of the present invention comprising a modified Tom2a gene is most preferably a plant of the species Cucumis sativus or Solanum lycopersicum. The plant of the present invention is preferably a cultivated plant, not a wild plant, which has agricultural value, in particular is agriculturally elite. The presence of a modified Tom2a gene preferably results in increased resistance to Cucumber Green Mottle Mosaic Virus (CGMMV) or Tomato Brown Rugose Fruit Virus (ToBRFV), optionally combined with resistance to another virus, in particular another tobamovirus. Resistance to CGMMV is preferably increased in plants of the Cucurbitaceae family, in particular Cucumis sativus (cucumber). Resistance to ToBRFV is preferably increased in plants of the Solanaceae family, in particular Solanum lycopersicum (tomato).

[0010] As used herein, a tobamovirus is in particular Cucumber green mottle mosaic virus (CGMMV) or Tomato brown rugose fruit virus (ToBRFV), but may also include other viruses belonging to the tobamovirus family, such as, for example, Pepper mild mottle virus (PMMoV), TMV, ToMV, ToMMV, BPMoV, TMGMV, PaMMV, WGMMV, ZGMMV, and KGMMV.

[0011] Phenotypic testing of cucumbers modified with the Tom2a gene to enhance resistance to CGMMV is performed by sowing seeds of the cultivars to be tested in standard seedling trays at 23°C. After 5 days, at least 10 seedlings are transplanted into larger pots. One week after sowing, the plants are planted and transferred to a temperature regime of 20°C day and 18°C ​​night. The inoculum is prepared by contacting the leaves of cucumber plants infected with CGMMV in 0.01M phosphate buffer (pH 7.0). The seedlings are then dusted with carborundum powder and the inoculum is gently rubbed into the leaves. Resistance is scored on a scale of 1 to 5. The explanation of the score scale is given in Table 1. Symptoms of cucumber seedlings in the bioassay are observed 14 to 21 days (dai) after inoculation. A susceptible (S) control without the modified Tom2a gene must be included, an example of which is the standard cultivar Ventura F1. The test is properly performed when the average score of the susceptible (S) controls, especially the Ventura F1, is higher than 4.9, preferably 5.0. Once this average is reached, scoring begins. The test is properly performed if plants are tested in at least two replicates, as is a standard prerequisite for all tests.

[0012] As used herein, plants that have increased CGMMV resistance due to the presence of a modified Tom2a gene have an average score of less than 4.0, preferably an average score of less than 3.5, more preferably an average score of less than 3.0, and most preferably an average score of less than 2.8, when scored according to Table 1.

[0013] [Table 1]

[0014] Phenotypic testing for ToBRFV resistance is performed by sowing seeds of the target cultivar to be tested in standard seedling trays. After 14-21 days, the seedlings are transplanted into larger pots. Preferably at least 10 seedlings, optimally at least 20 seedlings, are inoculated 4 weeks after sowing. The inoculum is prepared by contacting the leaves of tomato plants infected with ToBRFV in 0.01 M phosphate buffer (pH 7.0) mixed with celite. The seedlings are then dusted with carborundum powder and the inoculum is gently rubbed into the leaves. Resistance is scored on a scale of 0-5. The explanation of the score scale is given in Table 7. Observation of symptoms of tomato seedlings in the bioassay is performed 14-21 days (dai) after inoculation.

[0015] ToBRFV resistance is determined by comparison with a control variety known to be susceptible to ToBRFV. Examples of ToBRFV susceptible tomato varieties that do not have the resistance-conferring Tom2a allele of the present invention on chromosome 8 include Livento F1, Adventure F1, or Eclipse F1. The test uses at least 10 plants of a line and takes an average score. The test is performed properly when the average score of the susceptible (S) controls is higher than 3.0, preferably higher than 3.5. When this average value is reached, it is the correct time to score the assay.

[0016] As used herein, a ToBRFV-resistant tomato plant homozygously containing a resistance-conferring Tom2a allele of the invention on chromosome 8 has an average score of 1.5 or less, preferably 1.0 or less, when using scoring according to Table 7 (Example 6, Figure 6).

[0017] As used herein, ToBRFV resistance means that the virus replication is reduced or abolished in plants infected with ToBRFV. The reduction in virus replication can be measured by qPCR testing. To determine whether ToBRFV virus replication is reduced or abolished in a line, virus titers are measured in leaf samples taken from at least five ToBRFV-infected plants of that line. Leaf punches with a diameter of 6 mm are taken from each plant and ground in 500 μl of PBS buffer. 50 μl of the resulting suspension is used in a 96-well KingFisher Flex isolation protocol to isolate leaf material using the innuPREP DNA / RNA Virus PLUS Kit. This represents the number of cycles required to obtain a virus PCR product using a program of 50°C for 5 minutes, 95°C for 20 seconds, 95°C for 10 seconds, and 60°C for 60 seconds, repeated 40 times.

[0018] To allow comparison of values ​​for samples of different sizes and backgrounds, the S. lycopersicum PHD reference gene, a tomato housekeeping gene, is included in the qPCR assay to obtain Cq_PHD values ​​corrected for sample amount variations. To accurately determine the final value of the viral titer, the Delta Cq method is used with PHD as the housekeeping gene and ToBRFV as the gene of interest. The final value is Cq_corr, calculated as Cq_ToBRFV - Cq_PHD. A plant is judged to have reduced ToBRFV viral replication if the average Cq_corr of at least five plant samples is higher than -11.00 or the average Cq-corr is at least 5.00 higher than the average Cq_corr of the susceptible control.

[0019] In one embodiment, the ToBRFV-resistant S. lycopersicum plant of the present invention comprises a knockout of the Tom2a gene of the present invention on chromosome 8, and has an average Cq_corr score, in descending order, higher than -6.00, -5.50, -5.00, -4.50, -4.00, -3.50, -3.00, -2.50, -2.00, -1.50, -1.00, -0.50, or 0.00. The knockout of the Tom2a gene leads to a loss of function, and the encoded protein is missing, reduced in function, or non-functional. The average Cq_corr score is preferably taken from at least 20 plants containing the same knockout event (Example 6, Figure 7).

[0020] The plant of the present invention comprises modified Tom2a gene in homozygous or heterozygous form.That is, modified Tom2a gene can be present on both chromosomes of a chromosome pair in the genome of the plant, or can be present only on one chromosome of a chromosome pair.The plant of the present invention includes inbred line, F1 cross, hybrid variety, open pollination variety, polyploid haploid or segregating population plant.

[0021] Plants of the present invention that have increased tobamovirus resistance due to the presence of a modified Tom2a gene do not require the presence of a tobamovirus resistance-conferring allele of the Tm-1 gene, the TOM1 gene, or the TOM3 gene to exhibit resistance.

[0022] The wild-type CDS sequence of the Tom2a gene of the present invention comprises SEQ ID NO:1 for Cucumis sativus or a homologous sequence of the Tom2a gene in another crop having at least 70% sequence identity to SEQ ID NO:1, in particular SEQ ID NO:2 for Cucumis melo, SEQ ID NO:3 for Citrullus lanatus, SEQ ID NO:4 for Cucurbita pepo, SEQ ID NO:5 for Solanum lycopersicum, and SEQ ID NO:6 for Capsicum annuum (Figure 1).

[0023] The wild-type Tom2a gene encodes a protein comprising SEQ ID NO:7 in Cucumis sativus or a Tom2a protein comprising a homologous sequence in another crop having at least 70% sequence similarity to SEQ ID NO:7, in particular SEQ ID NO:8 in Cucumis melo, SEQ ID NO:9 in Citrullus lanatus, SEQ ID NO:10 in Cucurbita pepo, SEQ ID NO:11 in Solanum lycopersicum, and SEQ ID NO:12 in Capsicum annuum (Figure 2).

[0024] The present invention relates to a modified Tom2a gene having a modification resulting in a modified Tom2a protein. As used herein, a Tom2a protein is a protein comprising SEQ ID NO:7 or comprising a sequence having at least 70% sequence similarity to SEQ ID NO:7.

[0025] As used herein, the Tom2a gene is a gene encoding a Tom2a protein. As used herein, the Tom2a gene is a gene comprising a wild-type CDS sequence as represented by SEQ ID NO: 1 in Cucumis sativus, or a homologous gene in another crop comprising a sequence having at least 70% sequence identity to SEQ ID NO: 1; or a gene encoding a Tom2a protein comprising SEQ ID NO: 7 in Cucumis sativus; or a gene encoding a homologous Tom2a protein in another crop comprising a sequence having at least 70% sequence similarity to SEQ ID NO: 7. As used herein, the gene optionally includes the 5'-UTR sequence, promoter, and 3'-UTR sequence of the gene.

[0026] As used herein, a homologous Tom2a gene in another crop other than Cucumis sativus comprises a homologous CDS sequence, which has at least 70%, preferably at least 71%, 73%, 74%, 75%, 77%, 80%, 83%, 85%, 87%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% sequence identity to SEQ ID NO: 1. A homologous Tom2a protein in another crop other than Cucumis sativus comprises a homologous protein sequence, which has at least 70%, preferably at least 72%, 75%, 77%, 80%, 81%, 83%, 85%, 87%, 90%, 93%, 95%, 96%, 97%, 98%, 99%, or 100% sequence similarity to SEQ ID NO: 7. The homologous Tom2a gene or protein is preferably a gene or protein present in a plant belonging to the Solanaceae family or a plant belonging to the Cucurbitaceae family, in particular Cucumis melo, Citrullus lanatus, Cucurbita pepo, Solanum lycopersicum or Capsicum annuum.

[0027] As used herein, sequence identity or sequence similarity refers to the percentage of nucleotides or amino acids that are identical or similar between two sequences after appropriate alignment of the sequences. Those skilled in the art will recognize, for example, BLAST, which can be used for both nucleotide and protein sequences. (登録商標)We know how to align sequences using sequence alignment tools such as . For the most important results, we should obtain the best alignment that gives the highest sequence identity or similarity score. The percentage of sequence identity or similarity is calculated by comparing over the length of the shortest sequence in the evaluation, whereby, in the present invention, the sequence included in such evaluation represents a gene, including at least the start codon and the stop codon, or the complete protein encoded by such a gene. Sequence identity is used to compare nucleotide sequences. Sequence similarity is used to compare amino acid sequences, where conservative amino acid substitutions are considered to be similar, and is calculated here based on the BLOSUM62 scoring matrix.

[0028] Tom2a protein is a tetraspanin protein, a protein with tetraspanin / peripherin domains. The protein contains N- and C-terminal tails, as well as four transmembrane domains (TM1-4), which are connected by two non-cytoplasmic and one very short cytoplasmic loop (Figure 4). The second non-cytoplasmic loop, the extracellular loop (EC2), has various conserved regions, and this loop is thought to play an essential role in the function of tetraspanins in both animal and plant cells. Polar residues in the transmembrane domain seem to be essential for stabilizing the tertiary structure of the protein. It has also been described that the C-terminal tail of the protein is an important region for the proper functioning of tetraspanins.

[0029] In one aspect, the modification in the Tom2a gene results in a modified Tom2a protein having at least one amino acid deletion, substitution or insertion when compared to SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, or SEQ ID NO:12, or when compared to another homologous wild-type sequence of SEQ ID NO:7.

[0030] The modification of the Tom2a gene that results in tobamovirus resistance, particularly resistance to CGMMV or ToBRFV, can change the activity and / or function of the encoded protein. The modification in the Tom2a gene of the present invention includes a modification that results in an amino acid substitution in the encoded protein, a modification that results in a premature stop codon that results in truncation of the encoded protein, or a modification that results in a frameshift. A modification that results in a frameshift is a modification that includes the insertion or deletion of at least one nucleotide. A frameshift mutation usually causes a knockout of the gene, making it non-functional. The modification causes the encoded protein to be deleted, functionally altered, functionally reduced, or non-functional. The modification of the present invention is particularly an induced modification. An induced modification does not exist in nature, resulting in a non-naturally modified Tom2a gene, and thus a non-naturally modified Tom2a protein.

[0031] In one embodiment, the modified Tom2a protein has a modification in the second non-cytoplasmic extracellular loop. In one embodiment, the modified Tom2a protein has a modification in the transmembrane domain, particularly the TM2 domain. In one embodiment, the modified Tom2a protein has a modification in the cytoplasmic loop. In one embodiment, the modified Tom2a protein has a modification in the C-terminal tail. Modification of the C-terminal tail can result in a truncated protein, which may lead to a deletion or shortening of the C-terminal tail, in which case it cannot perform its function. In one embodiment, the modified Tom2a protein has a modification in the non-CP EC1 loop or the non-CP EC2 loop. In one embodiment, the modified Tom2a protein comprises a combination of the above modifications.

[0032] In one aspect, the modified Tom2a protein is truncated and comprises only amino acids 1 to 267 or fewer of SEQ ID NO:7, or a corresponding number of amino acids of a homologous Tom2a protein sequence, or the modified Tom2a protein comprises modifications in amino acids 268 to 279 of SEQ ID NO:7 that result in altered function, reduced function, or a non-functional protein, or comprises modifications in the corresponding amino acids of the homologous Tom2a protein sequence, in particular amino acids of SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, or SEQ ID NO:12.

[0033] In one embodiment, the modified Tom2a gene is a knockout.In one embodiment, the knockout results in a protein that lacks C-terminal tail; lacks TM4 domain and C-terminal tail; lacks non-CP EC2 loop and TM4 domain and C-terminal tail; lacks TM3 domain and non-CP EC2 loop and TM4 domain and C-terminal tail; lacks CP loop and TM3 domain and non-CP EC2 loop and TM4 domain and C-terminal tail; or lacks TM2 domain and CP loop and TM3 domain and non-CP EC2 loop and TM4 domain and C-terminal tail.In one embodiment, the knockout results in a protein that has truncated non-CP EC1 loop.Knockout genes can be caused by frameshift mutations or mutations that otherwise result in premature stop codons or other mutations that lead to loss of function of genes or encoded proteins.

[0034] In one embodiment, the modification resulting in a modified Tom2a protein that increases tobamovirus resistance comprises a C802T modification in cucumber SEQ ID NO: 1, or a modification at the corresponding position in a homologous sequence of SEQ ID NO: 1. The nucleotide change results in a Q268stop modification in cucumber SEQ ID NO: 7, or a modification at the corresponding position in a homologous protein sequence of SEQ ID NO: 7.

[0035] Modified Tom2a proteins that increase tobamovirus resistance include proteins having the Q268stop modification of SEQ ID NO: 7 in cucumber, or a modification at the corresponding position of a homologous sequence having at least 70% sequence similarity to SEQ ID NO: 7. This modification is representative of a modification in the C-terminal tail of the Tom2a protein.

[0036] For Solanum lycopersicum, the Tom2a variants GGC312-314del, A559G substitution, G673A, and A844G are described in co-pending PCT / EP2021 / 070104, which result in the A105del variant, the R187G substitution, the G225S substitution, and the T282A substitution, respectively, in the S. lycopersicum Tom2a protein sequence of SEQ ID NO:11.

[0037] The present invention relates to extrapolated modifications of said S. lycopersicum modifications to corresponding positions on other Tom2a genes that result in increased resistance to tobamoviruses, in particular increased resistance to CGMMV or ToBRFV. Extrapolation of amino acid positions can be performed using protein sequence alignments, and is shown for the particular Tom2a proteins listed herein in Figure 2.

[0038] In one embodiment, the modification resulting in a modified Tom2a protein that increases tobamovirus resistance comprises one or more of the TGC306-308del modification, the C553G modification, the G658A modification, or the A829G modification in SEQ ID NO: 1 of cucumber, or one or more modifications at the corresponding positions in a homologous sequence of SEQ ID NO: 1. The nucleotide changes respectively result in the A103del modification, the R185G amino acid substitution, the G220S amino acid substitution, or the T277A amino acid substitution in SEQ ID NO: 7 of cucumber, or modifications at the corresponding positions in a homologous protein sequence of SEQ ID NO: 7.

[0039] Modified Tom2a proteins that increase tobamovirus resistance include proteins with the A103del modification, the R185G amino acid substitution, the G220S amino acid substitution, or the T277A amino acid substitution of SEQ ID NO:7 in cucumber, or with modifications at the corresponding positions of homologous sequences with at least 70% sequence similarity to SEQ ID NO:7. The A103del modification is representative of modifications in the transmembrane domain, especially the TM2 domain. This modification may also affect the short cytoplasmic loop. The R185G, G220S and T277A modifications are representative of modifications in the C-terminal tail of the Tom2a protein (see FIG. 4).

[0040] The CDS of the modified cucumber Tom2a gene, resulting in a modified Tom2a protein with the Q268stop modification, which increases tobamovirus resistance, is shown in SEQ ID NO: 13 and the resulting truncated protein is shown in SEQ ID NO: 14 (Figure 3).

[0041] In one embodiment, the modified Tom2a gene encodes a modified Tom2a protein comprising a combination of modifications disclosed herein on any of the corresponding positions of SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, or SEQ ID NO:12, or another homologous sequence having at least 70% sequence similarity to SEQ ID NO:7. In one embodiment, the protein encoded by the modified Tom2a gene retains a combination of two, three, or four of these modifications. Table 2 provides an overview of a number of nucleotide and resulting amino acid modifications.

[0042] [Table 2]

[0043] As used herein, at least 70% sequence identity preferably relates to sequences having at least 70%, 71%, 73%, 74%, 75%, 77%, 80%, 81%, 83%, 85%, 87%, 90%, 92%, 94%, 95%, 96%, 97%, 98%, or 99% increasing sequence identity.

[0044] As used herein, at least 70% sequence similarity preferably relates to sequences having at least 70%, 72%, 75%, 77%, 80%, 81%, 83%, 85%, 87%, 90%, 93%, 95%, 96%, 97%, 98%, or 99% increasing sequence similarity.

[0045] As used herein, an "X000Y" mutation, modification, SNP, or substitution means that the wild-type sequence has a nucleotide or amino acid X on position 000 which is changed to a nucleotide or amino acid Y in the modified sequence. The designation "X000del" means that the modification is a deletion of the nucleotide or amino acid at that position. The designation "X000stop" means that the modification involves a truncation of the protein starting at that position, which is the result of the gene having a mutation that results in a premature stop codon.

[0046] The present invention further relates to a seed comprising the modified Tom2a gene of the present invention, and a plant grown from said seed is a plant of the present invention. In a preferred embodiment, the modified Tom2a gene of the present invention is homozygously present in the seed. The present invention also relates to a seed produced by a plant of the present invention, said seed carrying the modified Tom2a gene of the present invention, and as such, a plant grown from said seed is a plant of the present invention. The present invention also relates to the use of said seed to produce a plant of the present invention by growing said seed into a plant. The present invention also relates to a plant of the present invention, including a fruit or a seed, said plant comprising a modified Tom2a gene in its genome.

[0047] The present invention also relates to a fruit harvested from a plant of the present invention, which comprises in its genome a modified Tom2a gene of the present invention. The fruit is also referred to herein as a "fruit of the present invention". Furthermore, the present invention also relates to a food or processed food comprising a fruit or a part of said fruit of a plant of the present invention. The food may have undergone one or more processing steps. Such processing steps may include, but are not limited to, any one of the following treatments or combinations thereof: peeling, cutting, washing, juicing, cooking, cooling, or preparing a salad mix comprising the fruit of the present invention. The resulting processed food is also part of the present invention.

[0048] The present invention further relates to a method for producing seeds, comprising growing a plant from a seed of the present invention containing a modified Tom2a gene of the present invention, allowing the plant to produce a fruit with seeds, harvesting the fruit and extracting the seeds. The seed production is preferably carried out by crossing with itself or with another plant, which is also a plant of the present invention, if necessary. The seed thus produced can grow into a plant containing the modified Tom2a gene of the present invention. In a preferred embodiment, the modified Tom2a gene is homozygously present in the plant used for seed production. This method particularly relates to the production of seeds of Cucumis sativus or Solanum lycopersicum.

[0049] The present invention further relates to a hybrid seed and a method for producing said hybrid seed, comprising crossing a first parent plant with a second parent plant and harvesting the resulting hybrid seed, wherein the first parent plant and / or the second parent plant is a plant of the present invention comprising the modified Tom2a gene of the present invention. The resulting hybrid seed and the hybrid plant that can be grown from the hybrid seed are also part of the present invention. In a preferred embodiment, the parent plants homozygously comprise the modified Tom2a gene of the present invention, and the hybrid seed homozygously comprises the modified Tom2a gene of the present invention. The hybrid seed is in particular a seed of Cucumis sativus or Solanum lycopersicum.

[0050] The present invention also relates to a method for producing a plant with increased resistance to viruses of the Tobamovirus genus, in particular CGMMV or ToBRFV, comprising introducing a modification into the Tom2a gene, which modification results in increased resistance. The introduced modification comprises a deletion, substitution or insertion in the coding sequence of the Tom2a gene. Such a modification may result, for example, in a codon change, a premature stop codon, or a frameshift. The introduced modification preferably results in a modified Tom2a protein that contains an amino acid substitution, a truncated protein with a premature stop codon, a deletion of one or more amino acids, or a change in the amino acid sequence due to a frameshift. The introduction of such modifications can be carried out using a mutagenesis approach using chemicals such as ethyl methanesulfonate (EMS) or physical means such as UV irradiation, fast neutron irradiation, or other irradiation techniques.

[0051] Modifications can also be introduced using more specific and targeted approaches, such as homologous recombination, oligonucleotide-based mutagenesis, targeted genome editing using zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), or the clustered regularly interspaced short palindromic repeats (CRISPR) system, including the CRISPR / Cas system. In this way, the endogenous susceptible Tom2a gene can be edited to create a Tom2a gene that enhances tobamovirus resistance.

[0052] The present invention relates in particular to a method for producing Cucurbitaceae or Solanaceae plants with increased tobamovirus resistance, in particular CGMMV resistance in Cucurbitaceae or ToBRFV resistance in Solanaceae, comprising introducing a modification in the Tom2a gene comprising SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5 or SEQ ID NO: 6, or another homologous sequence having at least 70% sequence identity with SEQ ID NO: 1. In particular, the method comprises the introduction of a modification resulting in a Tom2a protein with altered, reduced or no function. In one embodiment, the introduced modification results in a truncated protein, wherein the truncated protein comprises the first 267 remaining amino acids or less of SEQ ID NO: 7, or the corresponding number of amino acids of a homologous Tom2a protein sequence, in particular comprising SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11 or SEQ ID NO: 12. In one aspect, the introduced alteration (modification) results in an alteration in one or more of amino acids 268-279 of SEQ ID NO:7, resulting in an altered, reduced function or non-functional protein, or an alteration in the corresponding amino acids of a homologous Tom2a protein sequence, in particular SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11 or SEQ ID NO:12. The method particularly relates to the production of Cucumis sativus plants with improved CGMMV resistance.

[0053] The introduction of the modified Tom2a gene of the present invention can be carried out by introduction from a donor plant containing said modified Tom2a gene, in particular from another plant that is resistant to tobamovirus and in which the modified Tom2a gene of the present invention has been identified, to a recipient plant that does not carry the modified Tom2a gene or that has the modified Tom2a gene heterozygously. Breeding methods that result in the transfer of genetic sequences from the donor plant to the recipient plant can be used, such as crossing and selection, backcrossing, recombination selection, etc. The donor plant, preferably a resistant plant, can be of the same species or of a different species and / or a wild species. Difficulties in interspecies crossing can be overcome by techniques known in the art, such as embryo rescue, or cisgenesis can be applied. Plants produced in such a way are also part of the present invention.

[0054] Alternatively, the modified Tom2a gene of the present invention can be transferred or introduced from another sexually incompatible plant, for example by using a transgenic approach. Techniques that may be suitably used include common plant transformation techniques known to those skilled in the art, such as the use of Agrobacterium-mediated transformation methods.

[0055] The present invention relates to the use of a modified Tom2a gene for increasing tobamovirus resistance in plants. The present invention also relates to the use of a modified Tom2a gene for developing a plant of the Solanaceae or Cucurbitaceae family with increased resistance to tobamoviruses, particularly CGMMV or ToBRFV. The use of the modified Tom2a gene includes introducing the gene into a plant.

[0056] The present invention further relates to the use of the plants of the invention in plant breeding. Thus, the present invention also relates to a breeding method for developing cultivated, preferably agronomically elite, plants with increased resistance to tobamoviruses, in particular CGMMV or ToBRFV, in which a plant containing a modified Tom2a gene of the invention is used to confer said resistance to another plant by introducing a modified Tom2a gene therein.

[0057] The present invention also relates to a method for producing a plant with increased resistance to a tobamovirus, in particular CGMMV or ToBRFV, comprising the steps of: a) crossing a plant of the invention containing a modified Tom2a gene of the invention with another plant; b) optionally subjecting the plants resulting from the cross of step a) to one or more selfing and / or crossings to obtain further generation populations; c) selecting from the population resulting from the cross of step a) or from the population of further generations of step b) plants that contain a modified Tom2a gene as defined herein and that have increased resistance to tobamoviruses, in particular CGMMV or ToBRFV. Includes.

[0058] In a preferred embodiment, the method relates to the production of Cucumis sativus plants with increased resistance to CGMMV or Solanum lycopersicum plants with increased resistance to ToBRFV.

[0059] The present invention also relates to a method for producing a plant with increased resistance to a tobamovirus, in particular CGMMV or ToBRFV, comprising the steps of: a) crossing a first parent plant containing a modified Tom2a gene of the present invention with a second parent plant which is a plant not containing a modified Tom2a gene of the present invention; b) backcrossing the plant obtained in step a) with a second parent plant for at least three generations; c) selecting from the third or more backcross populations plants that contain at least the modified Tom2a gene of the original parent plant of step a). Includes.

[0060] In a preferred embodiment, the method relates to the production of Cucumis sativus plants with increased CGMMV resistance or Solanum lycopersicum plants with increased ToBRFV resistance.

[0061] The present invention further provides a backcrossing method for introducing another desired trait into a plant having increased resistance to a tobamovirus, in particular CGMMV or ToBRFV, comprising the steps of: a) crossing a plant containing a modified Tom2a gene of the present invention with a second plant containing other desired traits to produce F1 progeny; b) optionally selecting in the F1 plants which contain the modified Tom2a gene and other desired traits; c) optionally, mating the selected F1 progeny with either parent to produce backcross progeny; d) selecting backcross progeny containing increased tobamovirus resistance and other desired traits; and e) Optionally, repeating steps c) and d) one or more successive times to produce selected fourth or more backcross progeny having increased tobamovirus resistance and other desired traits. The present invention provides a method comprising:

[0062] Backcrossing may be performed, if desired, until the backcross progeny are stable and can be used as parental lines, obtained by backcrossing three to ten times.

[0063] In one embodiment, the other desired trait is resistance to the same tobamovirus to which the presence of the modified Tom2a gene increases resistance, but the resistance of the other desired trait is caused by a gene other than the Tom2a gene. This approach, known as resistance stacking, results in stronger and more durable tobamovirus resistance in the plants of the invention, in particular stronger and more durable CGMMV or ToBRFV resistance.

[0064] In a preferred embodiment, the backcrossing method described above concerns the introduction of another desired trait in a Cucumis sativus plant with increased CGMMV resistance or a Solanum lycopersicum plant with increased ToBRFV resistance.

[0065] If desired, a selfing step is performed after the crossing or backcrossing step of the above method. Selection of plants containing the modified Tom2a gene of the present invention and other desired traits can alternatively be performed after any crossing or selfing step of the method. Other desired traits can be selected from, but are not limited to, the following group: resistance to bacterial, fungal or viral diseases, insect or pest resistance, improved germination, plant size, plant variety, plant vigor, improved storability, larger fruit size, smaller fruit size, improved fruit quality, parthenocarpic fruit, water stress tolerance, heat stress tolerance, cold stress tolerance, and male sterility. The present invention includes the plants produced by this method and the fruits obtained therefrom.

[0066] The present invention further relates to methods for producing plants containing the modified Tom2a gene of the present invention by using tissue culture or by using budding propagation.

[0067] The present invention further provides a method for producing plants containing the modified Tom2a gene of the present invention by using doubled haploid production techniques to generate doubled haploid lines that are fully homozygous and therefore homozygously contain the modified Tom2a gene of the present invention and have increased resistance to tobamoviruses, particularly CGMMV or ToBRFV.

[0068] The present invention further relates to a method for producing a plant comprising a modified Tom2a gene of the present invention, wherein the presence of said modified Tom2a gene confers increased resistance to tobamovirus, the method comprising growing said plant with seeds comprising said modified Tom2a gene.

[0069] The present invention relates to a method for identifying a plant comprising a modified Tom2a gene of the present invention, comprising determining the presence of an alteration in the Tom2a gene comprising SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5 or SEQ ID NO:6 or in a homologous sequence of SEQ ID NO:1, and optionally analysing whether the plant comprising the alteration has increased resistance to tobamoviruses, in particular CGMMV or ToBRFV. The method relates to identifying a plant of a species belonging to the Cucurbitaceae or Solanaceae family, in particular to identifying a plant of a species belonging to the Cucumis or Tomato genus. Preferably, the method relates to identifying a Cucumis sativus plant comprising a modified Tom2a gene, or to identifying a wild tomato species, in particular the species Solanum pimpinellifolium, comprising a modified Tom2a gene, or to identifying a plant of the species Solanum lycopersicum, comprising a modified Tom2a gene.

[0070] Determining the presence of a modification in the Tom2a gene includes identifying any modification in SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, or SEQ ID NO:6, or another homologous sequence of SEQ ID NO:1, that results in increased tobamovirus resistance, in particular increased CGMMV resistance or ToBRFV resistance. Determining the presence of a modification includes any of the modifications described herein, in particular the C802T, TGC306-308del, C553G, G658A, or A829G modifications of SEQ ID NO:1, as shown in Table 2. Determining the presence of a modification can be performed by sequence comparison of the wild-type Tom2a sequence with the Tom2a sequence of the plant being analyzed, and methods for performing sequence comparisons are known to those skilled in the art. To determine the presence of a particular modification, it is preferable to use a marker designed to identify such a modification, such that its sequence constitutes that particular modification relative to the wild-type sequence.

[0071] The present invention further relates to a method for selecting plants with increased resistance to tobamoviruses, particularly CGMMV or ToBRFV, which comprises identifying a modified Tom2a gene of the present invention in a plant and then selecting said plant as a plant with increased resistance to tobamoviruses, particularly CGMMV or ToBRFV. Optionally, the increased virus resistance can be confirmed by carrying out a bioassay as described herein. The selected plants obtained by such a method are also part of the present invention.

[0072] The present invention also relates to a method for testing a plant for the presence of a modified Tom2a gene of the present invention that increases tobamovirus resistance, in particular CGMMV resistance or ToBRFV resistance, comprising detecting the presence of a polymorphism leading to said increased resistance in SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5 or SEQ ID NO: 6, or another homologous sequence of SEQ ID NO: 1, in the genome of the plant. The method for testing a plant for the presence of a modified Tom2a gene of the present invention optionally further comprises selecting a plant containing the modified Tom2a gene as a plant having increased tobamovirus resistance, in particular increased CGMMV or ToBRFV resistance. The plant thus selected can then be used as a source for introducing a modified Tom2a gene into a plant lacking said allele.

[0073] The present invention also relates to a propagation material suitable for producing a plant of the present invention, said propagation material being suitable for sexual reproduction, in particular selected from microspores, pollen, ovaries, follicles, embryo sacs and egg cells, or suitable for reproduction, in particular selected from cuttings, roots, stem cells and protoplasts, or suitable for tissue culture of regenerable cells, in particular selected from leaves, pollen, embryos, cotyledons, hypocotyls, meristematic cells, roots, root tips, anthers, flowers, seeds and stems, wherein the plant produced from the propagation material comprises a modified Tom2a gene of the present invention as defined herein, which confers increased resistance to tobamoviruses, in particular CGMMV or ToBRFV. The plant of the present invention can be used as a source of propagation material.

[0074] The present invention further relates to a cell comprising the modified Tom2a gene of the present invention as defined herein. The cell of the present invention may be obtained from or present in a plant of the present invention. Such a cell may be in isolated form, or may be part of or derived from a whole plant, and such a cell still constitutes a cell of the present invention, since it contains the genetic information determining the modified Tom2a gene as described herein. Each cell of the plant of the present invention carries the modified Tom2a gene of the present invention, thereby carrying the genetic information leading to increased tobamovirus resistance. The cell of the present invention may also be a regenerable cell that can be regenerated into a new plant of the present invention. In the present specification, the presence of genetic information refers to the presence of the modified Tom2a gene of the present invention, where the modified Tom2a gene is as defined herein.

[0075] The present invention further relates to plant tissues of the plants of the present invention that contain the modified Tom2a gene of the present invention. The tissues can be undifferentiated tissues or already differentiated tissues. Undifferentiated tissues, such as stem tips, anthers, petals, or pollen, can be used for micropropagation to obtain new plants that grow into new plants of the present invention. Tissues can also be propagated from cells of the present invention.

[0076] The present invention further relates to the progeny of the plant, cell, tissue or seed of the present invention, which progeny contain the modified Tom2a gene of the present invention. Such progeny may themselves be plants, cuttings, cells, tissues or seeds.

[0077] As used herein, "progeny" is intended to mean the initial progeny and all further progeny, such as F1, F2, or further generations, from a cross with a plant of the invention, where the cross includes a cross with itself or with another plant, and the progeny (progeny) determined to be progeny contain a modified Tom2a gene of the invention that confers increased tobamovirus resistance. Progeny also includes plants or plant material containing a modified Tom2a gene of the invention obtained from a plant or progeny of a plant of the invention by budding or other forms of propagation.

[0078] The present invention further relates to a part of a plant of the invention suitable for sexual reproduction, which part of the plant comprises a modified Tom2a gene of the invention as defined herein, such part being for example selected from the group consisting of a microspore, a pollen, an ovary, a cumulus, an embryo sac and an egg cell.

[0079] Furthermore, the present invention relates to a part of a plant of the present invention suitable for bud propagation, in particular a cutting, root, stem, cell or protoplast, which contains a modified Tom2a gene of the present invention as defined herein. As mentioned above, a part of a plant is considered as propagation material. The plant produced from the propagation material contains a modified Tom2a gene of the present invention, the presence of which increases the resistance to tobamoviruses.

[0080] The present invention further relates to tissue cultures of plants of the present invention, which are also propagation materials and contain in their genome the modified Tom2a gene of the present invention. The tissue cultures contain regenerative cells. Such tissue cultures may be selected from or derived from any part of the plant, in particular leaves, pollen, embryos, cotyledons, hypocotyls, meristematic cells, roots, root tips, anthers, flowers, seeds, or stems. The tissue cultures may be regenerated into plants containing the modified Tom2a gene of the present invention, where the regenerated plants have increased tobamovirus resistance, which is also part of the present invention.

[0081] The present invention also relates to a marker for identifying a modified Tom2a gene in a plant, which comprises any of the modifications of the Tom2a gene described herein, thereby allowing said modification to be identified. Such an identifying marker comprises a nucleotide sequence which contains a specific polymorphism in its sequence when compared to the same sequence stretch of the wild-type Tom2a gene, which polymorphism results in a modification of the encoded protein that alters the function or activity of the Tom2a protein.

[0082] Markers of the invention are in particular markers comprising in their sequence any one of T at position 802, a deletion at positions 306-308, G at position 553, A at position 658 and G at position 829, where the positions are relative to SEQ ID NO:1, and which contain nucleotides in their sequence which represent the C802T, TGC306-308del, C553G, G658A or A829G modifications in SEQ ID NO:1 or which represent polymorphisms resulting in modifications at the corresponding positions in the homologous sequence, and which are therefore suitable for identifying any of those modifications in the Tom2a gene.

[0083] Nucleotide sequences comprising said polymorphisms, which are thereby suitable for identifying the polymorphisms in SEQ ID NO:1, are shown as SEQ ID NO:15 for identifying the C802T variant, SEQ ID NO:16 for identifying the TGC306-308del variant, SEQ ID NO:17 for identifying the C553G variant, SEQ ID NO:18 for identifying the G658A variant, and SEQ ID NO:19 for identifying the A829G variant. Nucleotide sequences constituting said polymorphisms, which are suitable for identifying the corresponding polymorphisms on the corresponding positions of SEQ ID NO:5, are shown as SEQ ID NO:20 for identifying the C817T variant, SEQ ID NO:21 for identifying the GGC312-314del variant, SEQ ID NO:22 for identifying the A559G variant, SEQ ID NO:23 for identifying the G673A variant, and SEQ ID NO:24 for identifying the A844G variant. The Tom2a gene is present on the minus strand of the published S. lycopersicum genome, and therefore the marker sequences of SEQ ID NOs:20-24 are shown as reverse complements in relation to SEQ ID NO:5.

[0084] If necessary, the sequence used as marker can be lengthened on both sides of the modification to ensure that it is unique in the genome and located in the Tom2a gene. The sequence surrounding the polymorphism is according to SEQ ID NO: 1 for Cucumis sativus, according to SEQ ID NO: 5 for Solanum lycopersicum, or according to a sequence with at least 70% sequence identity therewith, in particular according to SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, or SEQ ID NO: 6 for other crops.

[0085] The present invention also relates to the use of markers for identifying modified Tom2a genes, in particular markers represented by any one of SEQ ID NOs: 15 to 24. The present invention further relates to the use of markers, in particular markers as described herein, in particular for the identification of modified Tom2a genes in Cucumis sativus or Solanum lycopersicum or Solanum pimpinellifolium plants, which result in increased tobamovirus resistance, and / or for the selection of Cucumis sativus or Solanum lycopersicum or Solanum pimpinellifolium plants, which contain a modified Tom2a gene which results in increased tobamovirus resistance, in particular increased CGMMV resistance or ToBRFV resistance. The present invention also relates to the selection of plants identified by the markers described herein, and to the plants thus selected.

[0086] The present invention is further described in the following examples, which are for illustrative purposes only and are not intended to limit the invention in any manner. In the examples and herein, reference is made to the following figures: [Brief description of the drawings]

[0087] [Figure 1]FIG. 1 shows the CDS sequences of the wild-type Tom2a genes of Cucumis sativus (SEQ ID NO: 1), Cucumis melo (SEQ ID NO: 2), Citrullus lanatus (SEQ ID NO: 3), Cucurbita pepo (SEQ ID NO: 4), Solanum lycopersicum (SEQ ID NO: 5), and Capsicum annuum (SEQ ID NO: 6), and an alignment of SEQ ID NOs: 1 to 6. [Diagram 2] FIG. 2 shows the protein sequences of the wild-type Tom2a genes of Cucumis sativus (SEQ ID NO: 7), Cucumis melo (SEQ ID NO: 8), Citrullus lanatus (SEQ ID NO: 9), Cucurbita pepo (SEQ ID NO: 10), Solanum lycopersicum (SEQ ID NO: 11), and Capsicum annuum (SEQ ID NO: 12), and an alignment of SEQ ID NOs: 7 to 12. [Diagram 3] FIG. 3 shows the CDS sequence (SEQ ID NO: 13) and protein sequence (SEQ ID NO: 14) of modified CsTom2a that confers CGMMV resistance. [Figure 4] FIG. 4 shows the prediction of transmembrane protein portions and domains of Tom2a protein of a. Cucumis sativus and b. Solanum lycopersicum. [Diagram 5] FIG. 5 shows the nucleotide sequences representing the marker sequences SEQ ID NOs:15-24. [Figure 6] FIG. 6 shows the results of phenotypic analysis of Tom2a knockout mutants in S. lycopersicum. [Figure 7] FIG. 7 shows viral titration of Tom2a knockout mutants in S. lycopersicum. EXAMPLES

[0088] Example 1 Tom2a TILLING mutants in Cucumis sativus To develop new mutations for various traits, we developed a large TILLING population in Cucumis sativus using ethyl methanesulfonate (EMS) as a mutagen. In the search for new resistances, the TILLING approach was applied to various genes and multiple screens were performed on more than 3000 plants over several years. A screen performed in 2016 identified three mutants in the Tom2a gene, two more in 2017, and a sixth in 2019. All these mutants were selected for follow-up observations as they may result in interesting amino acid changes or premature stop codons (Table 3).

[0089] Other mutations caused by EMS treatment were removed, and several rounds of selfing were first performed focusing on maintaining the specifically identified mutation in the Tom2a gene to obtain plants with the desired mutation.

[0090] [Table 3]

[0091] The 2016 screen included a very interesting C802T mutation, which resulted in a truncated protein containing only the first 267 amino acids of the wild-type protein. This mutant, assigned the code “Mutant 2720”, was one of the first mutants to undergo several selfing steps and was selected for the first round of phenotypic observation for virus resistance. It was further backcrossed with the line used to develop the EMS population, named “KK1”, and a segregating population was developed. Segregating populations allow a good comparison of the phenotypes of plants with and without a particular mutation.

[0092] Example 2 Phenotypic analysis of CGMMV-resistant Q268stop mutants in Cucumis sativus A population of cucumber lines of the Q268stop mutant “2720” was selfed twice, selecting for the presence or absence of the C802T mutation. After these selfs, phenotypic analysis of CGMMV resistance was performed.

[0093] To perform the bioassay, mutant seeds were sown, along with CGMMV susceptible KK1 and Ventura F1 as controls. Seeds were sown at 23°C in standard seedling trays. After 5 days, 30 mutant and 30 control seedlings were transferred to a larger tray. Mutant and control plants were divided into three replicates. Unfortunately, only 17 mutant plants survived: 7 in the first replicate, 4 in the second, and 6 in the third. One week after sowing, the plants were replanted and transferred to a temperature regime of 20°C during the day and 18°C ​​at night. The inoculum was prepared by contacting cucumber leaves infected with CGMMV in 0.01 M phosphate buffer (pH 7.0). The seedlings were then dusted with carborundum powder, and the leaves were gently rubbed with the inoculum.

[0094] Resistance was scored on a scale of 1–5 according to the scoring scale description in Table 1. Symptom observations of cucumber seedlings in bioassays were performed 14–21 days after inoculation (dai). Scores are shown in Table 4: a / b / c / d / e correspond to a scale of 1 / 2 / 3 / 4 / 5. The mutants showed a clear increase in CGMMV resistance over the susceptible controls.

[0095] [Table 4]

[0096] Example 3 Modification of the Tom2a gene to confer resistance to tobamoviruses Modifications are introduced into the seeds of plants that require resistance to tobamoviruses, particularly CGMMV in cucurbits and ToBRFV in solanaceae. Modifications are introduced by mutagenesis, radiation means, such as EMS treatment, or specific targeting approaches, such as CRISPR / Cas system. When using non-targeting approaches, such as EMS, this is combined with identification techniques, such as TILLING. In this way, both in mutagenesis and targeted modification means, the modification of Tom2a gene can be made and identified. Those skilled in the art are familiar with these means for introducing modifications into the genome of the plant of interest.

[0097] The modified seeds are then germinated, the plants are grown, and crossed or self-crossed to generate seeds of M2 or higher generation. Then, the plants are screened to identify the modification of the Tom2a gene based on the comparison with the wild-type sequence of the Tom2a gene of the species. For example, for Cucumis sativus, a comparison should be made with SEQ ID NO: 1. For Solanum lycopersicum, a comparison should be made with SEQ ID NO: 5. Those skilled in the art are familiar with techniques to identify nucleotide changes, such as TILLING (McCallum et. al. (2000) Nature Biotechnology, 18: 455-457) to identify mutations in specific genes, and DNA sequencing.

[0098] The plants with the modified Tom2a gene are homozygous or are made homozygous by selfing, crossing, or using polyploid haploid techniques well known to those skilled in the art. The plants identified and selected based on the modification of the Tom2a gene can then be tested for resistance to tobamoviruses, particularly resistance to CGMMV or ToBRFV. The plants thus produced, identified, and selected are confirmed to have the virus resistance as a result of one or more modifications of the Tom2a gene.

[0099] Example 4 Tom2a TILLING mutants of Solanum lycopersicum A large TILLING population of Solanum lycopersicum was developed to develop new mutations for various traits. In the search for new tobamovirus resistance, the TILLING approach was applied to various genes, and multiple screens were conducted over the years. A total of 10 mutants causing protein changes were found in the Tom2a gene. According to SIFT predictions, four of these mutants were predicted to be tolerated, while the others were either lethal or resulted in truncated proteins. These mutants, especially those predicted to be deleterious or resulting in truncated proteins, were selected for phenotypic follow-up observations, as they result in potentially interesting amino acid changes or premature stop codons (Table 5).

[0100] To obtain a generation suitable for performing bioassays for tobamovirus resistance, particularly ToBRFV resistance, several rounds of selfing and backcrossing have been carried out to obtain plants carrying only the mutations of interest.

[0101] [Table 5]

[0102] Example 5 Generation of Tom2a CRISPR mutants in Solanum lycopersicum Using a ToBRFV-susceptible S. lycopersicum in-breeding line, a targeted knockout of the Tom2a gene was developed using the CRISPR / Cas9 editing system to observe the effect on ToBRFV resistance. The susceptible S. lycopersicum line was determined to have a wild-type Tom2a sequence represented by SEQ ID NO:5. The gene sequence (annotated) was used to design a large number of potential single guide RNAs (sgRNAs). Two sgRNAs with high on-target scores and low off-target scores were then selected. The Tom2a gene contains six exons, and one of the sgRNAs targeted the exon 1 position. The other sgRNA targeted the exon 5 position. The sgRNAs used are shown in Table 6.

[0103] [Table 6]

[0104] The two selected sgRNAs were used in Agrobacterium tumefaciens-mediated transformation with CRISPR / Cas9 constructs according to the protocol described in Pan, C. et al, CRISPR / Cas9-mediated efficient and heritable targeted mutagenesis in tomato plants in first and later generations. Sci. Rep. 6, 24765 (2016).

[0105] The combination of two sgRNAs resulted in multiple events in the Tom2a gene. Mutant plants were affected at both target sites. Two lines were selected with mutations in the Tom2a gene. Both mutants had a 1-bp insertion in exon 1 at position 157 of SEQ ID NO:5, causing a frameshift. One of the mutants had a 1-bp insertion in exon 5 at position 737 of SEQ ID NO:5. The other mutant contained two different events: a 2-bp deletion in exon 5 at positions 736 and 737 of SEQ ID NO:5. The targeted mutations resulted in a knockout of the Tom2a gene. Seeds from the mutants were propagated to the T2 generation. The mutations were homozygous in the T2 generation, and this generation was tested for ToBRFV resistance. Eight T2 lines with combinations of mutations in exon 1 and exon 5 were selected for phenotypic analysis.

[0106] Example 6 Phenotypic analysis of symptoms and viral titers of Tom2a knockout strains in S. lycopersicum Eight T2 lines derived from plants with homozygous knockout of the Tom2a gene obtained by the CRISPR / Cas9 editing method described in Example 5 were phenotyped by ToBRFV bioassay. All lines had a 1 bp insertion in exon 1. Lines 3.71, 3.64 and 3.32 also had a 1 bp insertion in exon 5. Lines 3.62, 3.54, 3.38, 3.28 and 3.14 had a 2 bp deletion in exon 5 in addition to the insertion in exon 1.

[0107] Twenty seeds from the total number were sown in standard seedling trays, and the seedlings were transferred to larger pots after 2-3 weeks. The transplants were inoculated 4 weeks after sowing. The cultivar Eclipse F1 was used as a susceptible control. From some lines, none of the seeds germinated. Only 11 seeds from lines 3.14 and 3.71 could be inoculated, 10 seeds from line 3.38, and 6 seeds from line 3.64. The inoculum was prepared by contacting the leaves of tomato plants infected with ToBRFV in 0.01 M phosphate buffer (pH 7.0) mixed with Celite. The seedlings were then dusted with carborundum powder, and the leaves were gently rubbed with the inoculum. Resistance was scored on a scale of 0 to 5. The explanation of the score scale is shown in Table 7. Observations of symptoms of tomato seedlings in the bioassay were performed 14-21 days after inoculation.

[0108] [Table 7]

[0109] All the susceptible control lines showed a phenotypic score of 4, indicating a successful experiment. The Tom2a knockout mutants assayed showed excellent resistance. All had average scores below 1.0. Only a limited number of plants could be included for the 3.64 lines that were scored 1.0. The phenotypic scores are shown in Figure 6.

[0110] Apart from visual symptoms, the measurement of virus titer is also a very important aspect of virus resistance. The virus titer was measured in ToBRFV-infected leaf samples taken from 20 plants of each T2 line obtained by the method described in Example 5. As a susceptible control, the cultivar Eclipse F1 was used. A leaf punch of 6 mm diameter was taken from each plant and then crushed in 500 μl of PBS buffer. 50 μl of the resulting suspension was used in a 96-well KingFisher Flex isolation protocol to isolate the leaf material using the innuPREP DNA / RNA Virus PLUS kit. The samples were then analyzed in a 96CFX qPCR thermocycler (Biorad) to obtain the Cq_ToBRFV value, which represents the number of cycles required to obtain a viral PCR product, using a program of 40 cycles of 50°C for 5 min, 95°C for 20 s, 95°C for 10 s, and 60°C for 60 s.

[0111] To allow comparison of values ​​for samples of different sizes and backgrounds, the S. lycopersicum PHD reference gene, a tomato housekeeping gene, was included in the qPCR assay to correct for variations in sample amount and obtain Cq_PHD values. To accurately determine the final value of the viral titer, the Delta Cq method was used with PHD as the housekeeping gene and ToBRFV as the gene of interest. The final value is Cq_corr, calculated as Cq_ToBRFV - Cq_PHD. Plants are judged to have reduced ToBRFV viral replication when the mean Cq_corr is higher than -11.00 or the mean Cq-corr is at least 5.00 higher than the mean Cq_corr of the susceptible controls.

[0112] The viral titer results for all knockout mutants were very convincing. The mean Cq_corr value for the sensitive controls was -16.21. The mean scores for all mutants were higher than -5.00, and most mutants were higher than 0.00. The viral titer results are shown in Figure 7.

[0113] It is concluded that the Tom2a knockout mutant of S. lycopersicum exhibits a significantly higher level of ToBRFV resistance in terms of not only in planta virus titers but also visual symptoms.

Claims

1. A plant comprising a modified Tom2a gene, wherein the wild type of the gene comprises SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5 or SEQ ID NO:6, or another homologous sequence having at least 70% sequence identity to SEQ ID NO:1, and wherein the modified gene confers increased resistance to tobamoviruses.

2. 2. The plant of claim 1, comprising a modification in the Tom2a gene that results in a modified Tom2a protein having at least one amino acid deletion, substitution or insertion compared to SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11 or SEQ ID NO:12, or compared to another homologous sequence having at least 70% sequence similarity to SEQ ID NO:

7.

3. A plant described in claim 1 or 2, wherein the modification results in a premature stop codon resulting in a truncated protein, or the Tom2a protein encoded by the modified Tom2a gene is deleted, functionally altered, functionally reduced or non-functional.

4. 3. The plant of claim 1 or 2, wherein the modification in the Tom2a protein is present in the transmembrane domain or C-terminal tail, or the modification in the Tom2a protein is present in Non-CP EC1 or Non-CP EC2.

5. 4. The plant of claim 3, wherein the modified Tom2a protein is truncated and comprises only amino acids 1 to 267 or fewer of SEQ ID NO: 7, or the corresponding number of amino acids of a homologous Tom2a protein sequence, or wherein the modified Tom2a protein comprises modifications in amino acids 268 to 279 of SEQ ID NO: 7, or in the corresponding amino acids of a homologous Tom2a protein sequence, in particular in amino acids SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, or SEQ ID NO: 12, which modifications result in an altered, reduced, or non-functional protein.

6. The plant of claim 5 , wherein the modified Tom2a protein comprises SEQ ID NO:

14.

7. 3. The plant according to claim 1 or 2, which is a plant of the Cucurbitaceae or Solanaceae family.

8. 8. The plant according to claim 7, which is a plant of the species Cucumis sativus, Cucumis melo, Citrullus lanatus, Cucurbita pepo, Solanum lycopersicum or Capsicum annuum, preferably a plant of the species Cucumis sativus or Solanum lycopersicum.

9. 8. The plant of claim 7, which is a plant of the Cucurbitaceae family and has increased resistance to CGMMV.

10. 8. The plant of claim 7, which is a plant of the Solanacae family and has increased resistance to ToBRFV.

11. A modified Tom2a gene encoding a Tom2a protein that contains at least one amino acid deletion, substitution or insertion compared to SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11 or SEQ ID NO:12, or compared to another homologous sequence having at least 70% sequence similarity to SEQ ID NO:

7.

12. 12. The modified Tom2a gene of claim 11, wherein the modified gene contains a premature stop codon and encodes a truncated Tom2a protein, or the Tom2a protein encoded by the modified Tom2a gene is deleted, has altered function, reduced function, or is non-functional.

13. 13. The modified Tom2a gene of claim 12, wherein the encoded modified Tom2a protein is truncated and comprises only amino acids 1 to 267 or fewer of SEQ ID NO: 7, or the corresponding number of amino acids of a homologous Tom2a protein sequence, or wherein the modified Tom2a protein comprises a modification in amino acids 268 to 279 of SEQ ID NO: 7, or in the corresponding amino acids of a homologous Tom2a protein sequence, in particular in amino acids of SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11 or SEQ ID NO: 12, which results in an altered, reduced function, or non-functional protein.

14. 13. A modified Tom2a gene as described in claim 11 or 12, wherein the presence of the modified gene in a plant results in increased resistance to tobamoviruses, in particular increased resistance to CGMMV in plants of the Cucurbitaceae family or increased resistance to ToBRFV in plants of the Solanaceae family.

15. A seed comprising the modified Tom2a gene of claim 11, wherein the plant grown from the seed is the plant of claim 2.

16. The use of markers, particularly markers comprising any one of SEQ ID NOs: 15-24, to identify modified Tom2a genes that confer increased tobamovirus resistance.

17. Use of the marker according to claim 16 for the identification of plants carrying a modified Tom2a gene.

18. 18. Use of a marker according to claim 16 or 17 for identifying increased tobamovirus resistance in plants.

19. A method for increasing tobamovirus resistance, particularly CGMMV resistance or ToBRFV resistance, in a plant, comprising introducing a modification into the Tom2a gene, wherein the modification results in a Tom2a gene as defined in claim 11 or 12.

20. A method for increasing tobamovirus resistance in plants, comprising introducing the modified Tom2a gene of claim 11 or 12 into the plant.

21. A method for producing a Cucurbitaceae or Solanaceae plant with increased tobamovirus resistance, particularly CGMMV resistance or ToBRFV resistance, comprising introducing a modification into a Tom2a gene comprising SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5 or SEQ ID NO:6, or another homologous sequence having at least 70% sequence identity to SEQ ID NO:

1.

22. The method described in claim 21, wherein the modification results in a Tom2a gene as defined in claim 11 or 12.

23. 1. A method for producing a plant with increased resistance to a tobamovirus, in particular CGMMV or ToBRFV, comprising: a) crossing the plant of claim 2 with another plant; b) optionally subjecting the plants resulting from the cross of step a) to one or more selfing and / or crossings to obtain a population of further generations; c) selecting plants comprising a modified Tom2a gene as defined in claim 11 from the population obtained from the cross of step a) or from the population of further generations of step b). , a production method.

24. 1. A method for producing hybrid seeds, comprising crossing a first parent plant with a second parent plant and harvesting the resulting hybrid seeds, wherein the first parent plant and / or the second parent plant is a plant according to claim 1, and wherein the hybrid plants grown from the seeds have increased tobamovirus resistance, particularly increased CGMMV resistance or ToBRFV resistance.

25. 25. The method of claim 24 for producing hybrid Cucumis sativus seeds with increased CGMMV resistance or for producing hybrid Solanum lycopersicum seeds with increased ToBRFV resistance.

26. 26. A hybrid seed produced by the method of claim 24 or 25.

27. 12. A method for identifying a plant containing a modified Tom2a gene as described in claim 11, wherein the identification comprises determining the presence of a modification in a Tom2a gene comprising SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, or another homologous sequence of SEQ ID NO:1, which modification results in a modified Tom2a protein having at least one amino acid deletion, substitution, or insertion compared to SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, or SEQ ID NO:12, or compared to another homologous sequence having at least 70% sequence similarity to SEQ ID NO:7, and optionally analyzing whether the plant containing the modification has increased resistance to tobamoviruses, particularly CGMMV or ToBRFV.

28. 12. Propagation material suitable for producing a plant according to claim 2, wherein the propagation material is suitable for sexual reproduction, in particular selected from microspores, pollen, ovaries, follicles, embryo sacs and egg cells, or suitable for reproduction, in particular selected from cuttings, roots, stem cells and protoplasts, or suitable for tissue culture of regenerable cells, in particular selected from leaves, pollen, embryos, cotyledons, hypocotyls, meristematic cells, roots, root tips, anthers, flowers, seeds and stems, and wherein plants produced from the propagation material have increased resistance to tobamoviruses, in particular CGMMV or ToBRFV.

29. A method for producing seeds, comprising growing a plant from the seed of claim 15 containing the modified Tom2a gene of claim 11, allowing the plant to produce fruit having seeds, harvesting the fruit, and extracting the seeds.

Images